Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - G1 Therapeutics, Inc. | gthx-ex322_7.htm |
| EX-31.2 - EX-31.2 - G1 Therapeutics, Inc. | gthx-ex312_9.htm |
| EX-31.1 - EX-31.1 - G1 Therapeutics, Inc. | gthx-ex311_10.htm |
| EX-23.1 - EX-23.1 - G1 Therapeutics, Inc. | gthx-ex231_8.htm |
| EX-4.2 - EX-4.2 - G1 Therapeutics, Inc. | gthx-ex42_212.htm |
| 10-K - GTHX-10K-2019 - G1 Therapeutics, Inc. | gthx-10k_20191231.htm |
Exhibit 32.1
CERTIFICATION UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of G1 Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: February 26, 2020 |
|
/s/ Mark A. Velleca, M.D., Ph.D. |
|
|
|
Mark A. Velleca, M.D., Ph.D. |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |